FILTER

Refine your search with the following facets to narrow down your results.

10 Current news of curasan

curasan AG: Novel bone regeneration material approved for sale in Europe

30-Mar-2011 - curasan AG has received European approval for a novel synthetic bone regeneration material. Osseolive® is a bioactive, poly-crystalline calcium-alkali-phosphate ceramic, which has a stimulating effect on bone formation as well as on bone mineralisation.“With Osseolive® emerging from our ...

bone regeneration ceramics curasan

curasan AG signs sales agreement with Stryker S.A.

11-Feb-2011 - curasan AG has signed an agreement with Stryker S.A., Montreux, Switzerland, to sell and market bone replacement and regeneration materials for different orthopedic indications. Starting summer 2011, Stryker anticipates launching the products in selected European countries to be potentially ...

bone replacement materials curasan

curasan AG: Bioactive bone regeneration material approved for sale in Europe

22-Oct-2010 - curasan AG has received European approval for its new granular bone regeneration material Ceracell®. Hans Dieter Rössler, CEO of curasan AG, considers the CE-certification of Ceracell® to be another milestone in the implementation of the product offensive launched at the beginning of the year: ...

biomaterials bone regeneration curasan

curasan AG: cooperation agreement for new product line

27-May-2010 - curasan AG has concluded a contract with Matricel GmbH, Herzogenrath, which secures exclusive rights for both companies over a jointly developed new product line. As manufacturer, Matricel GmbH will supply curasan AG, which in turn holds the marketing rights. In contrast to the bone augmentation ...

curasan phosphate

curasan AG: New US subsidiary for orthopaedics

22-Feb-2010 - curasan AG is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States. The newly founded curasan Inc., with its headquarters in Massachusetts, is responsible for commercial and logistical management as well as marketing ...

bone regeneration bone replacement materials bones +3

curasan AG receives license for Osbone

11-Dec-2009 - curasan AG has received CE certification and, therefore, marketing authorization throughout Europe of the synthetic bone replacement material Osbone®. Osbone® is suitable for utilisation in general bone surgery, particularly in implantology and oral and maxillofacial surgery associated with ...

atrophy bone replacement materials curasan +2

Ben-Gurion University Signs R&D Agreement with German Company curasan AG

12-Nov-2009 - Ben-Gurion University of the Negev’s technology transfer company BGN Technologies has signed a collaboration agreement with the German company curasan AG, to jointly develop special matrixes for bone regeneration. Curasan will invest 900,000 Euro in research to be performed by Dr. Hanna Rapaport ...

biomaterials biotechnology bone regeneration +5

curasan to invest approximately 1 million euros in future growth

15-Oct-2009 - curasan AG is to invest in its future growth by implementing a technological investment programme amounting to approximately 1 million euros, despite the current crisis in the financial markets. The aim of the investment package is to significantly strengthen and expand the company’s research, ...

bone replacement materials curasan documentation +1

curasan AG receives €1.48 million research grant

07-Sep-2009 - curasan AG has just received a grant of €1.48 million from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) for a bone regeneration research project scheduled to last three years. The funds are earmarked for a joint project with Ben Gurion ...

biomaterials bone regeneration Carrier +4

Change in Management Board of curasan AG

18-Mar-2004 - Kleinostheim. At the personal request of Mr. Helmut Trahmer and with the consent of the Supervisory Board his contract as Chief Financial Officer due to end on 31 December 2004 was terminated by mutual agreement and on friendly terms effective 31 March 2004. As of 1 April 2004, the ...

Aventis business development curasan +1